Voyager Therapeutics Inc (VYGR) Stock Analysis

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $4.23
• Market Cap: $227.40M
• EPS: $-2.17
• 52-Week High: $5.55
• 52-Week Low: $2.65

Market Sentiment

Voyager Therapeutics Inc currently has a Neutral sentiment score of -0.06.

About Voyager Therapeutics Inc

Voyager Therapeutics Inc. (VYGR) is a pioneering clinical-stage gene therapy company based in Cambridge, Massachusetts, specializing in the development of innovative treatments for severe neurological disorders. By leveraging its proprietary adeno-associated virus (AAV) platform, Voyager focuses on delivering targeted and sustained gene therapies that have the potential to transform patient outcomes in chronic neurological conditions. The company boasts a promising pipeline of investigational...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Voyager Therapeutics Inc and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does VYGR pay dividends?

Voyager Therapeutics Inc (VYGR) does not currently pay a regular dividend.

What is VYGR's market cap?

Voyager Therapeutics Inc (VYGR) has a market capitalization of $227.40M with a current stock price of $4.23.